Cargando…
Validation of the 2016 ASE/EACVI Guideline for Diastolic Dysfunction in Patients With Unexplained Dyspnea and a Preserved Left Ventricular Ejection Fraction
BACKGROUND: Echocardiography is considered the cornerstone of the diagnostic workup of heart failure with preserved ejection fraction. Thus far, validation of the 2016 American Society of Echocardiography/European Association of Cardiovascular Imaging (ASE/EACVI) echo‐algorithm for evaluation of dia...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649534/ https://www.ncbi.nlm.nih.gov/pubmed/34476984 http://dx.doi.org/10.1161/JAHA.121.021165 |
_version_ | 1784611016738340864 |
---|---|
author | van de Bovenkamp, Arno A. Enait, Vidya de Man, Frances S. Oosterveer, Frank T. P. Bogaard, Harm Jan Vonk Noordegraaf, Anton van Rossum, Albert C. Handoko, M. Louis |
author_facet | van de Bovenkamp, Arno A. Enait, Vidya de Man, Frances S. Oosterveer, Frank T. P. Bogaard, Harm Jan Vonk Noordegraaf, Anton van Rossum, Albert C. Handoko, M. Louis |
author_sort | van de Bovenkamp, Arno A. |
collection | PubMed |
description | BACKGROUND: Echocardiography is considered the cornerstone of the diagnostic workup of heart failure with preserved ejection fraction. Thus far, validation of the 2016 American Society of Echocardiography/European Association of Cardiovascular Imaging (ASE/EACVI) echo‐algorithm for evaluation of diastolic (dys)function in a patient suspected of heart failure with preserved ejection fraction has been limited. METHODS AND RESULTS: The diagnostic performance of the 2016 ASE/EACVI algorithm was assessed in 204 patients evaluated for unexplained dyspnea or pulmonary hypertension with echocardiogram and right heart catheterization. Invasively measured pulmonary capillary wedge pressure (PCWP) was used as the gold standard. In addition, the diagnostic performance of H(2)FPEF score and NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide) were evaluated. There was a poor correlation between indexed left atrial volume, E/e′ (septal and average) or early mitral inflow (E), and PCWP (r=0.25–0.30, P values all <0.01). No correlation was found in our cohort between e′ (septal or lateral) or tricuspid valve regurgitation and PCWP. The correlation between diastolic function grades of the ASE/EACVI algorithm and PCWP was poor (r=0.17, P<0.05). The ASE/EACVI algorithm had a sensitivity and specificity of 35% and 87%, respectively; an accuracy of 67% and an area under the curve of 0.56. Moreover, in 30% of cases the algorithm was not applicable or indeterminate. H(2)FPEF score had a modest correlation with PCWP (r=0.44, P<0.0001), and accuracy was 73%; NT‐proBNP correlated weakly with PCWP (r=0.24, P<0.001), and accuracy was 57%. CONCLUSIONS: The 2016 ASE/EACVI algorithm for the assessment of diastolic function has a limited diagnostic accuracy in patients evaluated for unexplained dyspnea and/or pulmonary hypertension, and especially sensitivity to detect diastolic dysfunction was low. |
format | Online Article Text |
id | pubmed-8649534 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86495342021-12-20 Validation of the 2016 ASE/EACVI Guideline for Diastolic Dysfunction in Patients With Unexplained Dyspnea and a Preserved Left Ventricular Ejection Fraction van de Bovenkamp, Arno A. Enait, Vidya de Man, Frances S. Oosterveer, Frank T. P. Bogaard, Harm Jan Vonk Noordegraaf, Anton van Rossum, Albert C. Handoko, M. Louis J Am Heart Assoc Original Research BACKGROUND: Echocardiography is considered the cornerstone of the diagnostic workup of heart failure with preserved ejection fraction. Thus far, validation of the 2016 American Society of Echocardiography/European Association of Cardiovascular Imaging (ASE/EACVI) echo‐algorithm for evaluation of diastolic (dys)function in a patient suspected of heart failure with preserved ejection fraction has been limited. METHODS AND RESULTS: The diagnostic performance of the 2016 ASE/EACVI algorithm was assessed in 204 patients evaluated for unexplained dyspnea or pulmonary hypertension with echocardiogram and right heart catheterization. Invasively measured pulmonary capillary wedge pressure (PCWP) was used as the gold standard. In addition, the diagnostic performance of H(2)FPEF score and NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide) were evaluated. There was a poor correlation between indexed left atrial volume, E/e′ (septal and average) or early mitral inflow (E), and PCWP (r=0.25–0.30, P values all <0.01). No correlation was found in our cohort between e′ (septal or lateral) or tricuspid valve regurgitation and PCWP. The correlation between diastolic function grades of the ASE/EACVI algorithm and PCWP was poor (r=0.17, P<0.05). The ASE/EACVI algorithm had a sensitivity and specificity of 35% and 87%, respectively; an accuracy of 67% and an area under the curve of 0.56. Moreover, in 30% of cases the algorithm was not applicable or indeterminate. H(2)FPEF score had a modest correlation with PCWP (r=0.44, P<0.0001), and accuracy was 73%; NT‐proBNP correlated weakly with PCWP (r=0.24, P<0.001), and accuracy was 57%. CONCLUSIONS: The 2016 ASE/EACVI algorithm for the assessment of diastolic function has a limited diagnostic accuracy in patients evaluated for unexplained dyspnea and/or pulmonary hypertension, and especially sensitivity to detect diastolic dysfunction was low. John Wiley and Sons Inc. 2021-09-03 /pmc/articles/PMC8649534/ /pubmed/34476984 http://dx.doi.org/10.1161/JAHA.121.021165 Text en © 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Research van de Bovenkamp, Arno A. Enait, Vidya de Man, Frances S. Oosterveer, Frank T. P. Bogaard, Harm Jan Vonk Noordegraaf, Anton van Rossum, Albert C. Handoko, M. Louis Validation of the 2016 ASE/EACVI Guideline for Diastolic Dysfunction in Patients With Unexplained Dyspnea and a Preserved Left Ventricular Ejection Fraction |
title | Validation of the 2016 ASE/EACVI Guideline for Diastolic Dysfunction in Patients With Unexplained Dyspnea and a Preserved Left Ventricular Ejection Fraction |
title_full | Validation of the 2016 ASE/EACVI Guideline for Diastolic Dysfunction in Patients With Unexplained Dyspnea and a Preserved Left Ventricular Ejection Fraction |
title_fullStr | Validation of the 2016 ASE/EACVI Guideline for Diastolic Dysfunction in Patients With Unexplained Dyspnea and a Preserved Left Ventricular Ejection Fraction |
title_full_unstemmed | Validation of the 2016 ASE/EACVI Guideline for Diastolic Dysfunction in Patients With Unexplained Dyspnea and a Preserved Left Ventricular Ejection Fraction |
title_short | Validation of the 2016 ASE/EACVI Guideline for Diastolic Dysfunction in Patients With Unexplained Dyspnea and a Preserved Left Ventricular Ejection Fraction |
title_sort | validation of the 2016 ase/eacvi guideline for diastolic dysfunction in patients with unexplained dyspnea and a preserved left ventricular ejection fraction |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649534/ https://www.ncbi.nlm.nih.gov/pubmed/34476984 http://dx.doi.org/10.1161/JAHA.121.021165 |
work_keys_str_mv | AT vandebovenkamparnoa validationofthe2016aseeacviguidelinefordiastolicdysfunctioninpatientswithunexplaineddyspneaandapreservedleftventricularejectionfraction AT enaitvidya validationofthe2016aseeacviguidelinefordiastolicdysfunctioninpatientswithunexplaineddyspneaandapreservedleftventricularejectionfraction AT demanfrancess validationofthe2016aseeacviguidelinefordiastolicdysfunctioninpatientswithunexplaineddyspneaandapreservedleftventricularejectionfraction AT oosterveerfranktp validationofthe2016aseeacviguidelinefordiastolicdysfunctioninpatientswithunexplaineddyspneaandapreservedleftventricularejectionfraction AT bogaardharmjan validationofthe2016aseeacviguidelinefordiastolicdysfunctioninpatientswithunexplaineddyspneaandapreservedleftventricularejectionfraction AT vonknoordegraafanton validationofthe2016aseeacviguidelinefordiastolicdysfunctioninpatientswithunexplaineddyspneaandapreservedleftventricularejectionfraction AT vanrossumalbertc validationofthe2016aseeacviguidelinefordiastolicdysfunctioninpatientswithunexplaineddyspneaandapreservedleftventricularejectionfraction AT handokomlouis validationofthe2016aseeacviguidelinefordiastolicdysfunctioninpatientswithunexplaineddyspneaandapreservedleftventricularejectionfraction |